Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 9/20 | 0.82 |
| ▸ | MAPT | P10636 | 6/20 | 0.82 |
| ▸ | BACE1 | P56817 | 4/20 | 0.82 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.82 |
| ▸ | MMP9 | P14780 | 3/20 | 0.82 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.82 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.82 |
| ▸ | TSHR | P16473 | 2/20 | 0.82 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.82 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.82 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.82 |
| ▸ | MAOA | P21397 | 2/20 | 0.82 |
| ▸ | MAOB | P27338 | 2/20 | 0.82 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.82 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.82 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.82 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.82 |
| ▸ | TOP2A | P11388 | 2/20 | 0.82 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.82 |
| ▸ | STAT3 | P40763 | 2/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28047873 | 1.00 | APP (0.82) | APPMAPTBACE1NFKB1MMP9 | |
| SCHEMBL31206160 | 1.00 | APP (0.82) | APPMAPTBACE1NFKB1MMP9 | |
| Curcumin SCHEMBL29358937 | 0.90 | APP (1.00) | APPMAPTBACE1NFKB1MMP9 | |
| Curcumin SCHEMBL17629819 | 0.90 | APP (1.00) | APPMAPTBACE1NFKB1MMP9 | |
| Curcumin SCHEMBL29355906 | 0.90 | APP (1.00) | APPMAPTBACE1NFKB1MMP9 | |
| Curcumin SCHEMBL8440 | 0.90 | APP (1.00) | APPMAPTBACE1NFKB1MMP9 | |
| Curcumin SCHEMBL17629818 | 0.90 | APP (1.00) | APPMAPTBACE1NFKB1MMP9 | |
| Curcumin SCHEMBL8336603 | 0.90 | APP (1.00) | APPMAPTBACE1NFKB1MMP9 | |
| Curcumin SCHEMBL2804734 | 0.90 | APP (1.00) | APPMAPTBACE1NFKB1MMP9 | |
| Curcumin SCHEMBL6901740 | 0.90 | APP (1.00) | APPMAPTBACE1NFKB1MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114096155-B | Animal food composition | 马斯公司 | 2024-11-22 | — | — | CN | claimed |
| US-20220378810-A1 | ANIMAL FOOD COMPOSITION | MARS, INCORPORATED (US) | 2022-12-01 | — | — | US | claimed |
| EP-3993633-A1 | ANIMAL FOOD COMPOSITION | Mars Incorporated (US) | 2022-05-11 | — | — | EP | claimed |
| CN-114096155-A | Animal food composition | 马斯公司 | 2022-02-25 | — | — | CN | claimed |
| WO-2021229603-A2 | FORMULATION OF PURE DIMETHOXY CURCUMIN-HUMAN SERUM ALBUMIN AND A PROCESS FOR THE PREPARATION THEREOF | SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY (IN) | 2021-11-18 | — | — | WO | claimed |
| WO-2021003280-A1 | ANIMAL FOOD COMPOSITION | MARS, INCORPORATED (US) | 2021-01-07 | — | — | WO | claimed |
| CN-108404142-B | Magnetic resonance imaging nano carrier, nano drug-loading system and preparation method thereof | 暨南大学 | 2020-01-17 | — | — | CN | claimed |
| CN-108289476-A | Hydration of animals | 雀巢产品技术援助有限公司 | 2018-07-17 | — | — | CN | claimed |
| US-8535693-B2 | Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof | Laila Pharmaceuticals Private Limited (US) | 2013-09-17 | — | — | US | claimed |
| US-20110229532-A1 | PROCESS FOR NANOEMULSIFICATION OF CURCUMIN AND DERIVATIVES OF CURCUMIN | LAILA PHARMACEUTICALS PVT. LTD | 2011-09-22 | — | — | US | claimed |
| CN-119700914-A | Method for constructing neuroinflammation intervention animal model and screening active ingredients in turmeric dregs | 广东药科大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-114096155-B | Animal food composition | 马斯公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-118955263-A | Curcumin (curcumin) demethoxycurcumin and bisdemethylation preparation process of methoxy curcumin | 江西丹霞生物科技股份有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118955263-A | Curcumin (curcumin) demethoxycurcumin and bisdemethylation preparation process of methoxy curcumin | 江西丹霞生物科技股份有限公司 | 2024-11-15 | — | — | CN | disclosed |
| EP-3768237-B1 | LIVER PROTECTANT COMPOSITIONS AND THERAPEUTIC APPLICATIONS | SAMI SABINSA GROUP LTD (IN) | 2024-05-15 | — | — | EP | disclosed |
| CN-101227823-A | Method for preparing tetrahydroxycurcumin and tetrahydroxycurcumin concentrated components from Curcuma rhizome extract | GUKARAJI R G (IN) | 2008-07-23 | — | — | CN | disclosed |
| US-20070243132-A1 | Transdermal delivery of pharmaceutical agents | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-10-18 | — | — | US | disclosed |
| EP-0839037-A4 | BIOPROTECTANT COMPOSITION, METHOD OF USE AND EXTRACTION PROCESS OF CURCUMINOIDS | SABINSA CORP (US) | 1999-03-03 | — | — | EP | disclosed |
| EP-0839037-A1 | BIOPROTECTANT COMPOSITION, METHOD OF USE AND EXTRACTION PROCESS OF CURCUMINOIDS | Sabinsa Corporation (US) | 1998-05-06 | — | — | EP | disclosed |
| WO-1997003674-A1 | BIOPROTECTANT COMPOSITION, METHOD OF USE AND EXTRACTION PROCESS OF CURCUMINOIDS | SABINSA CORPORATION (US) | 1997-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110229532-A1 | PROCESS FOR NANOEMULSIFICATION OF CURCUMIN AND DERIVATIVES OF CURCUMIN | FABP4, LIPC, LIPA | APP 2924/4885MAPT 1998/4885BACE1 2626/4885 |
| US-20220378810-A1 | ANIMAL FOOD COMPOSITION | AGER, S100A4, TSLP | APP 1660/4885MAPT 2123/4885BACE1 3933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.